This inventor holds 1 USPTO granted patent. Top assignee: Orionis Biosciences, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Sarah Gerlo: Innovator in Immunostimulatory Adjuvants
Introduction
Sarah Gerlo is a prominent inventor based in Gent, Belgium. She has made significant contributions to the field of immunology, particularly through her innovative work on immunostimulatory adjuvants. With a focus on enhancing immune responses, her research has the potential to impact vaccine development and therapeutic strategies.
Latest Patents
Sarah Gerlo holds a patent for her invention titled "Immunostimulatory Adjuvants." This patent represents her commitment to advancing medical science and improving health outcomes through innovative solutions. The patent showcases her expertise and dedication to the field.
Career Highlights
Throughout her career, Sarah has been associated with Orionis Biosciences, Inc., where she has been able to apply her knowledge and skills in a collaborative environment. Her work at the company has allowed her to contribute to groundbreaking research and development in immunology.
Collaborations
Sarah collaborates with Jan Tavernier, a fellow researcher, to further enhance their work in the field. Their partnership exemplifies the importance of teamwork in driving innovation and achieving scientific breakthroughs.
Conclusion
In summary, Sarah Gerlo is a dedicated inventor whose work on immunostimulatory adjuvants is paving the way for advancements in immunology. Her contributions are vital to the ongoing efforts to improve health through innovative research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile